---
title: 'before you take peptides, know this.'
source: 'https://youtube.com/watch?v=7yYcjQc4A2g'
video_id: '7yYcjQc4A2g'
date: 2026-09-18
duration_sec: 67
channel: 'Bryan Johnson'
---

# before you take peptides, know this.

> Source: [before you take peptides, know this.](https://youtube.com/watch?v=7yYcjQc4A2g)

## Summary

The video is a critical analysis of the peptide industry, arguing that most users are misusing peptides by not closing the feedback loop with biomarker testing. It emphasizes that while peptides like GLP-1s are effective, proper use requires measuring biomarkers and addressing foundational health habits first.

### Key Points

- **Peptide Industry Explosion** [00:00] — The peptide industry is growing rapidly, but almost no one is using them correctly. The speaker is not anti-peptide and acknowledges that some, like GLP-1s, are highly effective.
- **The Open Loop Problem** [00:16] — Most people keep an 'open loop'—taking peptides based on feelings and escalating doses without data. The correct approach is a 'closed loop': take the peptide, measure the biomarker, and adjust accordingly.
- **Dose Escalation Without Clinical Precedent** [00:31] — Without biomarker feedback, doses can escalate based on subjective feelings rather than data, leading to doses without clinical precedent.
- **Skipping Foundational Health** [00:45] — People often reach for peptides before fixing sleep, nutrition, and exercise. Injections create an illusion of psychological control—the needle feels like power.
- **The Precision of the Body** [00:59] — The body is precise; the same peptide with the right dose can work for you, but with the wrong dose it can work against you. Without biomarkers, you don't know which side of the line you're on.

### Conclusion

Peptides are promising, but using them without biomarker measurement is like taking a shot in the dark. The key is to close the loop with data and address foundational health habits first.

## Transcript

Come here. I think we need to have a pep talk. A peptide pep talk. The peptide industry is exploding and almost no one is using them correctly. I want to be clear, I am not anti-peptide. In fact, some peptides, like the GLP-1s, are among the most effective interventions in the world.
The problem is twofold. First, most people keep an open loop. You take peptides, you feel something, you take more. The reality? You actually want it closed. You take the peptide, you measure the biomarker and then you adjust accordingly. Without the biomarker feedback, dose can escalate based
upon your feelings and not data. And that is how you get yourself in a situation where you're taking doses without clinical precedent. But really, that's only half the problem. People often reach for peptides before trying to fix sleep, nutrition, and exercise. Injections are attractive because
they create this illusion of psychological control. The needle, it feels like power. You've got to be careful though because the body is precise. The same peptide that works for you with the right dose can work against you with the wrong dose. And without biomarkers, you just don't
know what side of the line you're on. Peptides are very promising, but if you're not measuring biomarkers, you're taking a shot in the dark.